Skip to NavigationSkip to content

News

The Chairman of British Biotech has reiterated the company aim to pursue an acquisition or merger following the departure of Chief Executive Dr...
Alzheimer patients in a quarter of all health authorities are still not receiving the latest medicines despite NICE guidance being in place for...
New networks of excellence in pharmaceutical research must be established if Europe is to catch up with world leading US R&D communities,...
AstraZeneca has been boosted by the first regulatory approval in the Netherlands of Crestor, its uperstatincholesterol treatment.
Doctors' leaders have rejected Heath Secretary Alan Milburn latest idea to break the deadlock over the new consultant contract.
GlaxoSmithKline Consumer Healthcare is to expand its use of In2Focus sales representatives to promote its smoking cessation product NiQuitin CQ in...
A ban on advertising some OTC medicines could be lifted as part of the Government drive to create a patient-centred NHS.
Patients will be able to report adverse reactions to medicines direct to the NHS from next year, the Government has revealed.
AstraZeneca has launched a new fast acting nasal spray version of its migraine treatment Zomig.
The next generation of statins such as AstraZeneca Crestor could face a NICE review because of cost concerns, the Government Heart Czar Dr Roger...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile